Janux
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10955 Vista Sorrento Pkwy Ste 200, San D...Phone Number
(858) 751-4493Website
www.januxrx.comRevenue
$24 MillionStock Symbol
JANXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
3
1
1
2
2
1
About Janux
Janux Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing innovative immunotherapies for the treatment of cancer. The company specializes in creating next-generation biologic medicines that harness the power of the immune system to recognize and eliminate cancer cells while reducing unwanted effects on healthy tissues. Its research activities are centered on developing proprietary therapeutic platforms that improve the safety, precision, and effectiveness of cancer immunotherapy through advanced protein engineering and targeted immune activation.Explore more
Janux Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Janux your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Janux, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Janux launches new products
Earning: See what the market has to say on Janux recently announced quarterly report
Click to see if Janux had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Janux
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Janux is spiking on competitors!
Check if Janux has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Janux has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Janux
Compare insights from companies similar to Janux, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Janux is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Janux is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Janux.
Janux financials insights
Gather financial insights about Janux, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$56M
2024
Stock Offering
$402.5M
Janux Tech Stack
A closer look at the technologies used by Janux
See more technologies
Most Recent Scoops
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Janux News & Media
Where is Janux Therapeutics (JANX) Headed According to Analysts?
Janux Therapeutics, Inc. (NASDAQ:JANX) is one of the best immunotherapy stocks to buy according to hedge funds. JonesTrading maintained a Buy rating on Janux Therapeutics, Inc. (NASDAQ:JANX) on January 23, setting a price target of $50.00. The rating update came after Janux Therapeutics, Inc. (NASDAQ:JANX) announced on January 22 a collaboration and exclusive worldwide license […]Janux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer - Stock Titan
Former Kite Pharma leader behind pivotal ZUMA-1 trial joins Janux as CMO, as the company advances PSMA and EGFR TRACTr cancer programs into Phase 1.BMS bets on Janux’s novel solid tumour therapy through $850m deal
This deal marks another addition to BMS’s growing pipeline, which the company hopes will stave off the impacts of the upcoming patent cliff.Why Wall Street Sees Big Potential in Janux Therapeutics, Inc. (JANX)
Janux Therapeutics, Inc. (NASDAQ:JANX) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, Janux Therapeutics, Inc. (NASDAQ:JANX) has a consensus rating of buy or equivalent from the majority of the analysts covering the stock. The gap between the high and consensus low price targets is also wide: the […]
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Janux
Sign Up For FreeTo access detailed company insights
Janux Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing innovative immunotherapies for the treatment of cancer. The company specializes in creating next-generation biologic medicines that harness the power of the immune system to recognize and eliminate cancer cells while reducing u... Read More
